Phase Composition and Disorder in La2(Sn,Ti)2O7 Ceramics: New Insights from NMR Crystallography

La2(Sn,Ti)2O7 陶瓷中的相组成和无序性:NMR 晶体学的新见解

阅读:7
作者:Arantxa Fernandes, David McKay, Scott Sneddon, Daniel M Dawson, Sebastian Lawson, Richard Veazey, Karl R Whittle, Sharon E Ashbrook

Abstract

An NMR crystallographic approach, involving the combination of 119Sn NMR spectroscopy, XRD, and DFT calculations, is demonstrated for the characterization of La2Sn2-x Ti x O7 ceramics. A phase change from pyrochlore (La2Sn2O7) to a layered perovskite phase (La2Ti2O7) is predicted (by radius ratio rules) to occur when x ≈ 0.95. However, the sensitivity of NMR spectroscopy to the local environment is able to reveal a significant two-phase region is present, extending from x = 1.8 to ∼0.2, with limited solid solution at the two extremes, in broad agreement with powder XRD measurements. DFT calculations reveal that there is preferential site substitution of Sn in La2Ti2O7, with calculated shifts for Sn substitution onto Ti1 and Ti2 sites (in the "bulk" perovskite layers) in better agreement with experiment than those for Ti3 and Ti4 ("edge" sites). Substitution onto these two sites also produces structural models with lower relative enthalpy. As the Sn content decreases, there is a further preference for substitution onto Sn2. In contrast, the relative intensities of the spectral resonances suggest that Ti substitution into the pyrochlore phase is random, although only a limited solid solution is observed (up to ∼7% Ti). DFT calculations predict very similar 119Sn shifts for Sn substitution into the two proposed models of La2Ti2O7 (monoclinic (P21) and orthorhombic (Pna21)), indicating it is not possible to distinguish between them. However, the relative energy of the Sn-substituted orthorhombic phase was higher than that of substituted monoclinic cells, suggesting that the latter is the more likely structure.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。